Olink Proteomics products

The most comprehensive, high-performance protein biomarker panel available for cardiovascular and metabolic studies.

The most comprehensive, high-performance protein biomarker panels available for inflammation studies. The flexibility and scalability of our Olink Explore platform can be utilized either to screen our entire library of 3072 assays, or in studies that focus on one or several of the eight Explore 384-plex panels that make up the Explore 3072 protein library.

The most comprehensive, high-performance protein biomarker panels available for neurological studies. The flexibility and scalability of our Olink^® Explore platform can be utilized either to screen our entire library of 3072 assays, or in studies that focus on one or several of the eight Explore 384-plex panels that make up the Explore 3072 protein library.

Olink Target 48 Cytokine is the ultimate solution for cytokine studies and inflammation-related diseases. The thorough selection of biomarkers ensures that the most important proteins covering key pathways related to cytokine signaling and inflammatory processes are well covered. Inflammation is of central importance for biomedical research and is now believed to be a key underlying factor for the pathophysiology of a wide range of diseases, such as:

Casting a broader net to further explore the complexity of the human proteome. Complementing and expanding on our previous portfolio of disease area-focused biomarker panels, our exploratory panels offers scientists the chance to cast a wider net in the quest to identify new biomarkers and relevant protein signatures, offering many new assays focused on important biological processes with wide-ranging clinical relevance.

Towards a better understanding of cardiovascular disease and personalized medicine. The Cardiovascular II (CVD II) panel is a high-throughput, multiplex immunoassay enabling analysis of 92 CVD-related protein biomarkers across 96 samples simultaneously. This high level of multiplexing is achieved without any compromise on data quality, thanks to our proprietary Proximity Extension Assay (PEA) technology.

Towards a better understanding of cardiovascular disease and personalized medicine. The Cardiovascular III (CVD III) panel is a high-throughput, multiplex immunoassay enabling analysis of 92 CVD-related protein biomarkers across 96 samples simultaneously. This high level of multiplexing is achieved without any compromise on data quality, thanks to our proprietary Proximity Extension Assay (PEA) technology.

Casting a broader net to further explore the complexity of the human proteome. Complementing and expanding on our previous portfolio of disease area-focused biomarker panels, our exploratory panels offers scientists the chance to cast a wider net in the quest to identify new biomarkers and relevant protein signatures, offering many new assays focused on important biological processes with wide-ranging clinical relevance.

Casting a broader net to further explore the complexity of the human proteome. Complementing and expanding on our previous portfolio of disease area-focused biomarker panels, our exploratory panels offers scientists the chance to cast a wider net in the quest to identify new biomarkers and relevant protein signatures, offering many new assays focused on important biological processes with wide-ranging clinical relevance.